Literature DB >> 7378216

Acute haemodynamic effects of oral prazosin in severe mitral regurgitation.

J Mehta, R L Feldman, W W Nichols, C J Pepine, C R Conti.   

Abstract

Acute haemodynamic effects of single dose oral prazosin were studied in eight patients with mitral regurgitation. Heart rate, mean systemic arterial pressure, pulmonary arterial pressure, left ventricular filling pressure, and forward cardiac output were measured in all patients. At peak effect, prazosin reduced mean systemic arterial pressure (95 +/- 4 to 86 +/- 4 mmHg), pulmonary arterial pressure (45 +/- 6 to 23 +/- 4 mmHg), and left ventricular filling pressure (30 +/- 4 to 21 +/- 3 mmHg). Pulmonary and systemic vascular resistance also fell (316 +/- 49 to 208 +/- 43 dynes s cm-5 and 2132 +/- 148 to 1491 +/- 94 dynes s cm-5, respectively). Forward cardiac index increased from 1.89 +/- 0.12 to 2.43 +/- 0.13 l/min per m2 and stroke volume from 43 +/- 5 to 57 +/- 6 ml/beat after prazosin. The onset of these changes occurred between 15 and 30 minutes, peaked between 45 and 60 minutes, and persisted for six hours. These data indicate that in patients with mitral regurgitation oral prazosin promptly improves cardiac performance (judged by increased forward cardiac output and reduced left ventricular filling pressure) as systemic and pulmonary vascular resistance are reduced.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7378216      PMCID: PMC482341          DOI: 10.1136/hrt.43.5.556

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  18 in total

1.  Afterload reduction therapy with nitroprusside in severe aortic regurgitation: improved cardiac performance and reduced regurgitant volume.

Authors:  R R Miller; L A Vismara; A N DeMaria; A F Salel; D T Mason
Journal:  Am J Cardiol       Date:  1976-11-04       Impact factor: 2.778

2.  Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.

Authors:  R R Miller; N A Awan; K S Maxwell; D T Mason
Journal:  N Engl J Med       Date:  1977-08-11       Impact factor: 91.245

Review 3.  Measurement of blood flow by thermodilution.

Authors:  W Ganz; H J Swan
Journal:  Am J Cardiol       Date:  1972-02       Impact factor: 2.778

4.  Effect of nitroprusside on left ventricular dynamics in mitral regurgitation.

Authors:  D J Goodman; R M Rossen; E L Holloway; E L Alderman; D C Harrison
Journal:  Circulation       Date:  1974-11       Impact factor: 29.690

5.  Improved left ventricular function during nitroprusside infusion in acute myocardial infarction.

Authors:  J A Franciosa; C J Limas; N H Guiha; E Rodriguera; J N Cohn
Journal:  Lancet       Date:  1972-03-25       Impact factor: 79.321

6.  Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvar apparatus.

Authors:  K Chatterjee; W W Parmley; H J Swan; G Berman; J Forrester; H S Marcus
Journal:  Circulation       Date:  1973-10       Impact factor: 29.690

7.  Vasodilators in the treatment of heart failure.

Authors:  J Mehta
Journal:  JAMA       Date:  1977-12-05       Impact factor: 56.272

Review 8.  Vasodilator therapy of cardiac failure: (first of two parts).

Authors:  J N Cohn; J A Franciosa
Journal:  N Engl J Med       Date:  1977-07-07       Impact factor: 91.245

Review 9.  The role of vasodilator therapy in heart failure.

Authors:  K Chatterjee; W W Parmley
Journal:  Prog Cardiovasc Dis       Date:  1977 Jan-Feb       Impact factor: 8.194

10.  Clinical use of sodium nitroprusside in chronic ischemic heart disease. Effects on peripheral vascular resistance and venous tone and on ventricular volume, pump and mechanical performance.

Authors:  R R Miller; L A Vismara; R Zelis; E A Amsterdam; D T Mason
Journal:  Circulation       Date:  1975-02       Impact factor: 29.690

View more
  2 in total

1.  Effects of isosorbide dinitrate on rheumatic and non-rheumatic mitral regurgitation.

Authors:  M K Jeang; L J Petrovich; A V Adyanthaya; J Alexander
Journal:  Tex Heart Inst J       Date:  1986-12

Review 2.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.